Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Spitzweg

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|July 20, 2007
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasoneMichael J Willhauck, Bibi Sharif-Samani, Reingard Senekowitsch-Schmidtke, et al.
Human Gene Therapy|April 15, 2011
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryKathrin Klutz, Michael J Willhauck, Nathalie Wunderlich, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2020
Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic MorphologyTheresa Vogel, Julia Wendler, Karin Frank-Raue, et al.
European Radiology|July 21, 2016
The added value of <sup>68</sup>Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine originPhilipp M Kazmierczak, Axel Rominger, Vera Wenter, et al.
Molecular Imaging|May 15, 2014
Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomographyWalter Koch, Christoph J Auernhammer, Julia Geisler, et al.
Cancers|November 18, 2020
Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC PatientsFreba Ahmaddy, Vera Wenter, Harun Ilhan, et al.
Polymers|April 12, 2019
Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA NanoparticlesStephan Morys, Ana Krhac Levacic, Sarah Urnauer, et al.
BMC Cancer|February 8, 2021
The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective studyVera Wenter, Nathalie L Albert, Freba Ahmaddy, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 8, 2021
An unusual case of struma ovariiViktoria F Koehler, Patrick Keller, Elisa Waldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Cost-Effectiveness of [<sup>177</sup>Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 TrialAdrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|July 20, 2007
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasoneMichael J Willhauck, Bibi Sharif-Samani, Reingard Senekowitsch-Schmidtke, et al.
Human Gene Therapy|April 15, 2011
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryKathrin Klutz, Michael J Willhauck, Nathalie Wunderlich, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2020
Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic MorphologyTheresa Vogel, Julia Wendler, Karin Frank-Raue, et al.
European Radiology|July 21, 2016
The added value of <sup>68</sup>Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine originPhilipp M Kazmierczak, Axel Rominger, Vera Wenter, et al.
Molecular Imaging|May 15, 2014
Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomographyWalter Koch, Christoph J Auernhammer, Julia Geisler, et al.
Cancers|November 18, 2020
Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC PatientsFreba Ahmaddy, Vera Wenter, Harun Ilhan, et al.
Polymers|April 12, 2019
Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA NanoparticlesStephan Morys, Ana Krhac Levacic, Sarah Urnauer, et al.
BMC Cancer|February 8, 2021
The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective studyVera Wenter, Nathalie L Albert, Freba Ahmaddy, et al.
Endocrinology, Diabetes & Metabolism Case Reports|March 8, 2021
An unusual case of struma ovariiViktoria F Koehler, Patrick Keller, Elisa Waldmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Cost-Effectiveness of [<sup>177</sup>Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 TrialAdrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, et al.
Pageof 15